Banner Health- MD Anderson Cancer Center

Gilbert, Arizona 85234

3 studies enrolling now · 11 studies all time

What they study most

ALK-Positive Large B-Cell Lymphoma, AML, Acquired Resistance to KRAS G12C Inhibitor, Advanced Cancer, Advanced Solid Tumor, B-cell Lymphoma, BRAF, BRAF Gene Mutation, BRAF Mutation-Related Tumors, BRAF V600 Mutation, BRAF V600E, Bladder Cancer

Studies at this site

• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies — Recruiting now
• Study of SGR-1505 in Mature B-Cell Neoplasms — Recruiting now
• Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) — Running, not enrolling
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• ADSTILADRIN Early Utilization and Outcomes in the Real World Setting — Stopped early
• Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma — Completed
• A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma — Completed
• Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC — Status unconfirmed
• Project Survival-Prospective Biomarker Discovery — Status unconfirmed